JonathanAbramBernsteinMD

PubMed

• Clinical validity of dried blood spot assay for the measurement of functional C1 inhibitor in angioedema due to C1 inhibitor deficiency.
  Jonathan A Bernstein, Jie Cheng, Thomas Pisani, Dan Sexton, Rachel E Whitaker
  The Journal of Allergy and Clinical Immunology. Global. 2025-05-01
• Randomized trial of ultraviolet irradiation units installed in homes of children and adolescents with asthma.
  Jonathan A Bernstein, Anand Seth, Marepalli Rao, Janyce C Katz, Umesh Singh
  The Journal of Allergy and Clinical Immunology. Global. 2025-05-01
• Indirect treatment comparison of oral sebetralstat and intravenous recombinant human C1 esterase inhibitor for on-demand treatment of hereditary angioedema attacks.
  H Henry Li, Emel Aygören-Pürsün, Markus Magerl, Timothy J Craig, Michael E Manning
  Allergy, Asthma, and Clinical Immunology. 2025-03-15

Journal Articles

• Effect of Lanadelumab Compared with Placebo on Prevention of Hereditary Angioedema Attacks  
  Jonathan A Bernstein, Lawrence B Schwartz, Andrew M Smith, H James Wedner, Daniel Soteres, Timothy Craig, Douglas T Johnston, Aleena Banerji, Paula J Busse, William R ..., JAMA
• Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients with Chronic Idiopathic (Spontaneous) Urticaria  
  Jonathan A Bernstein, Michael D Tharp, Ivo Abraham, JAMA
• Correspondence and Reply Reply  
  Jonathan Bernstein, MD, ScienceDirect
• Population Pharmacokinetics of Subcutaneous C1‐Inhibitor for Prevention of Attacks in Patients with Hereditary Angioedema  
  Jonathan A Bernstein, Marc A Riedl, Bruce Zuraw, H Henry Li, Timothy Craig, William R Lumry, Clinical and experimental allergy
• The 24-h FEV1 time profile of olodaterol once daily via Respimat and formoterol twice daily via Aerolizer in patients with GOLD 2-4 COPD: results from two 6-week cross...  
  Feldman GJ, Bernstein JA, Hamilton A, Nivens MC, Korducki L, LaForce C, Springerplus, 8/9/2014
• Multinational experience with hypersensitivity drug reactions in Latin America  
  Jares EJ, Sanchez-Borges M, Cardona-Villa R, Ensina LF, Arias-Cruz A, Gomez M, Barayazarra S,Bernstein JA, Serrano CD, Cuello MN, Morfin-Maciel BM, De Falco A, Cherrez..., Ann Allergy Asthma Immunol, 7/24/2014
• Systemic and localized seminal plasma hypersensitivity patients exhibit divergent immunologic characteristics  
  Ghosh D, Bernstein JA, J Allergy Clin Immunol, 7/3/2014
• Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group  
  Cicardi M, Aberer W, Banerji A, Bas M, Bernstein JA, Bork K, Caballero T, Farkas H, Grumach A, Kaplan AP, Riedl MA, Triggiani M, Zanichelli A, Zuraw B; HAWK under the ..., Allergy, 5/1/2014
• The diagnosis and management of acute and chronic urticaria: 2014 update  
  Bernstein JA, Lang DM, Khan DA, Craig T, Dreyfus D, Hsieh F, Sheikh J, Weldon D, Zuraw B, Bernstein DI, Blessing-Moore J, Cox L, Nicklas RA, Oppenheimer J, Portnoy JM,..., J Allergy Clin Immunol, 5/1/2014
• Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial  
  Malbran A, Riedl M, Ritchie B, Smith WB, Yang W, Banerji A, Hébert J, Gleich GJ, Hurewitz D, Jacobson KW, Bernstein JA, Khan DA, Kirkpatrick H, Resnick D, Li H, Fernán..., Clin Exp Immunol, 4/22/2014
• Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial  
  Riedl MA, Bernstein JA, Li H, Reshef A, Lumry W, Moldovan D, Farkas H, Levy R, Baker J, Hardiman Y, Totoritis MC, Relan A, Cicardi M; Study 1310 Investigators, Ann Allergy Asthma Immunol, 2/1/2014
• Escalating doses of C1 esterase inhibitor (CINRYZE) for prophylaxis in patients with hereditary angioedema  
  Bernstein JA, Manning ME, Li H, White MV, Baker J, Lumry WR, Davis-Lorton MA, Jacobson KW, Gower RG, Broom C, Fitts D, Schranz J, J Allergy Clin Immunol Pract, 1/1/2014
• A consensus parameter for the evaluation and management of angioedema in the emergency department  
  Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA Jr, Collins SP, Craig TJ, Lumry WR, Nowak R, Pines JM, Raja AS, Riedl M, Ward MJ, Zuraw BL, Dier..., Acad Emerg Med, 1/1/2014
• A cross-sectional questionnaire assessing patient and physician use of short-term prophylaxis for hereditary angioedema  
  Nanda M, Singh U, Wilmot J, Bernstein JA, Ann Allergy Asthma Immunol, 1/1/2014
• Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis  
  Singh U, Bernstein JA, Prog Drug Res, 1/1/2014
• On-demand Therapy for Hereditary Angioedema  
  Bernstein JA, Immunol Allergy Clin North Am, 11/1/2013
• Contemporary approaches to the diagnosis and management of physical urticaria  
  Lang DM, Hsieh FH, Bernstein JA, Ann Allergy Asthma Immunol, 10/1/2013
• MP29-02: A breakthrough for the treatment of allergic rhinitis  
  Bernstein JA, Expert Opin Pharmacother, 10/1/2013
• Effect of time to treatment on response to C1 esterase inhibitor concentrate for hereditary angioedema attacks  
  Craig TJ, Rojavin MA, Machnig T, Keinecke HO, Bernstein JA, Ann Allergy Asthma Immunol, 9/1/2013
• Reply  
  Barnes CS, Alexis NE, Bernstein JA, Cohn JR, Demain JG, Levetin E, Phipatanakul W, J Allergy Clin Immunol Pract, 9/1/2013
• Nonallergic rhinitis: therapeutic options  
  Bernstein JA, Curr Opin Allergy Clin Immunol, 8/1/2013
• Fertility and human seminal plasma (HSP) hypersensitivity  
  Tan J, Bernstein JA, Ann Allergy Asthma Immunol, 8/1/2013
• A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema  
  Zuraw BL, Bernstein JA, Lang DM, Craig T, Dreyfus D, Hsieh F, Khan D, Sheikh J, Weldon D, Bernstein DI, Blessing-Moore J, Cox L, Nicklas RA, Oppenheimer J, Portnoy JM,..., J Allergy Clin Immunol, 6/1/2013
• Factors associated with hospitalization of patients with angiotensin-converting enzyme inhibitor-induced angioedema  
  Gang C, Lindsell CJ, Moellman J, Sublett W, Hart K, Collins S, Bernstein JA, Allergy Asthma Proc, 5/1/2013
• Successful intravaginal graded challenge after a systemic reaction with skin prick testing to seminal fluid  
  Baker TW, Ghosh D, Bernstein JA, Ann Allergy Asthma Immunol, 4/1/2013
• Join now to see all

Books/Book Chapters

• Capsaicin as a Therapeutic Molecule, Progress in Drug Research 
  Chapter: Intranasal Capsaicin in the Management of Non-allergic (vasomotor) Rhinitis 
  Singh, U, Bernstein JAEditors: O. M. E. Abdel-Salam.Springer, Basel2014
• Clinical Asthma: Theory and Practice 
  Editors: Bernstein JA and Levy M.InformaEdition 1st,2014
• Allergy 
  Chapter: Occupational Asthma To Low and High Molecular Weight Agents 
  Bernstein JAEditors: Mahmoudi M.McGraw Hill, New York2011
• Allergy 
  Chapter: Allergic Reactions Affecting Mucosal Surfaces 
  Page 201 - 214Bernstein JA and Sublett JWEditors: Mahmoudi M.McGraw Hill, New York2010
• Recent Advances in Aerobiology and Allergy 
  Chapter: Pharmacotherapy of Chronic Rhinitis and Asthma 
  Page 285 - 312Bernstein JA2008
• Nonallergic Rhinitis 
  Chapter: Questionnaire Diagnosis of Non-Allergic Rhinitis 
  Page 55 - 68Brandt D, Bernstein JAEditors: Baraniuk JN, Shusterman D.Marcel Dekker, Inc.2008
• Inhalation Aerosols: Physiologic and Biological Basis for Therapy 
  Chapter: Therapeutic Uses of Lung Aerosol 
  Page 219 - 252Bernstein JA, Amin H, Smith SEditors: Hickey AJ.Edition 2nd,2007
• Allergy 
  Chapter: Occupational Asthma 
  Page 145 - 155Bernstein JAEditors: Mahmoudi M.McGraw Hill, New York2007
• Current Reviews of Rhinitis 
  Chapter: Mixed Rhinitis: A New Subclass of Chronic Rhinitis? 
  Page 69 - 78Bernstein JA, Rezvani MEditors: Kaliner M.Current Medicine, IncEdition 2nd,2006
• Patterson’s Allergic Diseases 
  Chapter: Antihistamines 
  Page 65 - 80Bernstein JAEditors: Grammer LC and Greenberger PA.Lippincott Williams and Wilkins Co.Edition 6th,2002
• Immunology and Allergy Clinics of North America 
  Chapter: Cost Benefit Analysis for Immunotherapy 
  Page 593 - 607Bernstein JAEditors: Ledford DK.W.B. Saunders Co.2000
• Allergy in Primary Care 
  Chapter: Occupational Asthma 
  Page 193 - 204Orfan N, Montanaro A, Tilles SA, Bernstein JAEditors: Altman LC, Becker JW, Williams PV.W.B. Saunders Co.2000
• Environmental Asthma 
  Chapter: Occupational Asthma: Diagnostic Approaches and Treatment 
  Page 265 - 284Bernstein JA, Bernstein DIEditors: Bush R.Marcel Dekker, Inc.Edition 1st,2000
• Asthma in the Workplace 
  Chapter: Asthma Works: The English Version of the Telematic Information System (Minitel) on Occupational Asthma 
  Page 729 - 730Bernstein JA, Malo J-L, Dhivert-Donnadieu H, et.al.Editors: Bernstein, IL, Chan-Yeung M, Malo J-L, Bernstein DI.Marcel Dekker, Inc.Edition 2nd,1999
• Asthma in the Workplace 
  Chapter: Enzymes 
  Page 363 - 376Bernstein JA, Gaines WEditors: Bernstein, IL, Chan-Yeung M, Malo J-L, Bernstein DI.Marcel Dekker, Inc.Edition 2nd,1999
• Allergens and Allergen Immunotherapy 
  Chapter: Pharmacoeconomic Considerations for Allergen Immunotherapy 
  Page 445 - 454Bernstein JAEditors: Lockey RF, Fernandez-Caldas E, Bukantz S.Marcel Dekker, Inc., New York1998
• Contact Urticaria Syndrome 
  Chapter: Seminal Plasma Hypersensitivity 
  Page 241 - 260Bernstein JA, Bernstein DI, Bernstein ILEditors: Amin S, Lahti A,Maibach HI.CRC Press, Boca Raton1997
• Toxicology of Chemical Respiratory Hypersensitivity 
  Chapter: Occupational Respiratory Allergy 
  Page 29 - 59Bernstein JA, Bernstein DI, Bernstein ILEditors: Kimber I, Dearman RJ.Taylor and Francis, London1997
• Asthma 
  Chapter: Cromones 
  Page 1647 - 1666Bernstein JA, Bernstein ILEditors: Barnes P.Lippincott-Raven, Philadelphia1997
• Allergy 
  Chapter: Occupational induced asthma 
  Page 511 - 523Bernstein JA, Bernstein ILEditors: Kaplan A.W.B. Saunders Co., Philadelphia1997
• Inhalation Aerosols: Physical and Biological Basis for Therapy 
  Chapter: Therapeutic uses of lung aerosols 
  Page 233 - 269Smith P, Bernstein JAEditors: Hickey AJ.Marcel Dekker, New York1996
• Allergy,Clinical Immunology and Asthma Management in Infants, Children and Adults 
  Chapter: Occupational asthma 
  Page 529 - 548Bernstein JA, et alEditors: Bierman CW, et. al..W.B. Saunders Co., PhiladelphiaEdition 3rd,1995
• Immunotoxicology and Immunopharmacology 
  Chapter: Clinical Aspects of Respiratory Hypersensitivity to Chemicals 
  Page 617 - 642Bernstein JA, Bernstein ILEditors: Kimber I.Raven PressEdition 2nd,1994
• Bronchial Asthma: Mechanisms and Therapeutics 
  Chapter: Non-steroidal anti-allergic drugs 
  Page 854 - 875Bernstein JA, Bernstein ILEditors: Weiss EB, Stein M.Little Brown & Co, BostonEdition 3rd,1993
• Allergic Diseases Diagnosis and Management 
  Chapter: Antihistamines 
  Page 73 - 92Bernstein JAEditors: Patterson R, et. al..J.B. Lippincott Co., PhiladelphiaEdition 4th,1993
• Join now to see all

Lectures

• 3rd Annual North American Rhinology & Allergy Conference(NARAC) 
  North American Rhinology & Allergy Conference(NARAC), Fajardo, Puerto Rico - 1/31/2013

Other

• Talanta. Portable method of measuring gaseous acetone concentrations 
  Worrall AD, Bernstein JA, Angelopoulos AP
  8/1/2013
• New drug targets and future directions: Ecallantide 
  Bernstein JA
  http://www.futuremedicine.com
  1/1/2011
• Allergic Rhinitis and Asthma: Role of Environmental Determinants 
  Bernstein JA
  http://www.consultant.com
  7/1/2006
• Allergic Rhinitis and Asthma: How to Help Patients Control Environmental Triggers 
  Bernstein JA
  http://www.consultant.com
  7/1/2006
• Join now to see all